ACYCLOVIR IN HERPES ZOSTER

The Lancet

Volumn 318, Issue 8251, 1981, Pages 827-830

  Peterslund, N A ^a   Ipsen, J ^a   Schonheyder, H ^a   Seyer Hansen, K ^a   Esmann, V ^a   Juhl, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; PLACEBO;

CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG THERAPY; HERPES ZOSTER; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PAIN; PERIPHERAL NERVOUS SYSTEM; RANDOMIZED CONTROLLED TRIAL; THERAPY; VARICELLA ZOSTER VIRUS;

ACUTE DISEASE; ACYCLOVIR; AGED; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; GUANINE; HERPES ZOSTER; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PAIN; RANDOM ALLOCATION;

EID: 0019520255     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(81)91102-8     Document Type: Article

References (7)

1. Antiviral treatment of varicella zoster and herpes simplex
2. Selectivity of action of an antiherpetic agent, 9-(2-hydroxy-ethoxymethyl) guanine
3. Parenteral acyclovir therapy for herpes virus infections in man
4. Acyclovir treatment for mucocutaneous herpes simplex infections in immunocompromised patients
5. Treatment of herpes zoster with idoxuridine ointment, including a multivariate analysis of symptoms and signs
6. Treatment oftrigeminal and thoracic zoster with idoxuridine
7. Appropriate scores for clinical and public health variables